Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. We have developed an entirely novel, powerful and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs.


Biotechnology

Research

Protillion Biosciences

Curtis Layton

Nancy du

Adriana Arneson

Terrence M.

Robb Milley

David Heiner

Michael Gotrik

Pavan Vaidyanathan

Will Greenleaf

David Walt

The Leadership Team at Protillion Biosciences drives the strategic vision and operational execution of the company, leveraging their collective expertise to guide the development and commercialization of the novel protein display platform. They are responsible for making high-level decisions to advance the company's mission to revolutionize therapeutic antibody and binder discovery.

Leadership Team

Engineering and Scientific Team

Leadership Team

About

Team members

Other teams at Protillion Biosciences

Engineering and Scientific Team